Clinical Trials Logo

Filter by:
NCT ID: NCT00239421 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

Start date: November 2003
Phase: Phase 4
Study type: Interventional

To compare the efficacy and safety of tiotropium plus formoterol in comparison to salmeterol plus fluticasone in COPD patients.

NCT ID: NCT00239369 Completed - Hypertension Clinical Trials

Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

Start date: October 2005
Phase: Phase 3
Study type: Interventional

The primary objective of this trial is to demonstrate that a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 25 mg (T80/H25) is superior in reducing blood pressure after eight weeks compared with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg (T80/H12.5) in patients who fail to respond to six weeks treatment with T80/H12.5.

NCT ID: NCT00239343 Completed - Breast Cancer Clinical Trials

Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

Start date: October 2004
Phase: Phase 2
Study type: Interventional

The aim of the study is to estimate the effect of preoperative gefitinib on the complete pathological response rate in primary estrogen receptor negative breast cancer at the time of surgery.

NCT ID: NCT00238797 Completed - Glioblastoma Clinical Trials

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

Start date: February 2003
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine the efficacy of gefitinib (IressaTM) in combination with radiotherapy on patients with glioblastoma multiforme.

NCT ID: NCT00237913 Completed - Schizophrenia Clinical Trials

Schizophrenia Trial of Aripiprazole

Start date: July 2004
Phase: Phase 3
Study type: Interventional

Aripiprazole will show improved effectiveness over the standard of care treatment with one of three atypical antipsychotics (olanzapine, quetiapine and risperidone).

NCT ID: NCT00235950 Completed - Clinical trials for Coronary Heart Disease

Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease

Start date: January 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy between two lipid lowering treatments, rosuvastatin (10-40 mg) and atorvastatin (20-80 mg) in reducing low-density lipoprotein cholesterol (LDL-C) levels after 16 weeks of treatment in patients with coronary heart disease

NCT ID: NCT00234520 Completed - Acromegaly Clinical Trials

A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide

Start date: May 2003
Phase:
Study type: Observational

The aim of the study is to compare the risk of acromegaly patients developing valvular regurgitation when receiving lanreotide or octreotide

NCT ID: NCT00233441 Completed - Atrial Fibrillation Clinical Trials

Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter

MAIA
Start date: December 2004
Phase: Phase 2/Phase 3
Study type: Interventional

Double blind study to evaluate the efficacy and tolerability of SSR149744C and select a dose to be further investigated in the maintenance of sinus rhythm after electrical, pharmacological or spontaneous conversion of AF/AFL.

NCT ID: NCT00233025 Completed - Fibromyalgia Clinical Trials

Duloxetine Versus Placebo in the Treatment of FMS

Start date: September 2005
Phase: Phase 3
Study type: Interventional

To test the hypothesis that the efficacy and safety of duloxetine has beneficial effects of the reduction of pain severity as measured by the average pain item of the BPI and the PGI-I in patients with fibromyalgia syndrome.

NCT ID: NCT00232726 Completed - Neoplasm Metastasis Clinical Trials

Clinical Study of Previously Untreated Patients With Malignant Melanoma

Start date: September 2005
Phase: Phase 2
Study type: Interventional

Previously untreated patients with malignant melanoma receive a new chemotherapy drug currently under development. CP-4055 is given intravenously on days 1-5 every four weeks until complete response or disease progression.